Synektik S.A. (SNT) - Total Assets
Based on the latest financial reports, Synektik S.A. (SNT) holds total assets worth zł605.37 Million PLN (≈ $166.61 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Synektik S.A. net assets for net asset value and shareholders' equity analysis.
Synektik S.A. - Total Assets Trend (2010–2025)
This chart illustrates how Synektik S.A.'s total assets have evolved over time, based on quarterly financial data.
Synektik S.A. - Asset Composition Analysis
Current Asset Composition (December 2025)
Synektik S.A.'s total assets of zł605.37 Million consist of 68.7% current assets and 31.3% non-current assets.
| Asset Category | Amount (PLN) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 17.2% |
| Accounts Receivable | zł179.12 Million | 36.6% |
| Inventory | zł46.60 Million | 9.5% |
| Property, Plant & Equipment | zł0.00 | 0.0% |
| Intangible Assets | zł35.89 Million | 7.3% |
| Goodwill | zł3.65 Million | 0.8% |
Asset Composition Trend (2010–2025)
This chart illustrates how Synektik S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Synektik S.A. market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Synektik S.A.'s current assets represent 68.7% of total assets in 2025, an increase from 67.6% in 2010.
- Cash Position: Cash and equivalents constituted 17.2% of total assets in 2025, up from 3.7% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is accounts receivable at 36.6% of total assets.
Synektik S.A. Competitors by Total Assets
Key competitors of Synektik S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
SHE:300760
|
China | CN¥59.27 Billion |
|
Medacta Group SA
SW:MOVE
|
Switzerland | CHF860.76 Million |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $1.36 Billion |
|
Ningbo David Medical Device Co Ltd
SHE:300314
|
China | CN¥1.45 Billion |
|
T&L Co. Ltd
KQ:340570
|
Korea | ₩219.17 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
LENSAR Inc
NASDAQ:LNSR
|
USA | $70.20 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
Synektik S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.56 | 1.52 | 1.40 |
| Quick Ratio | 1.22 | 1.33 | 1.30 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | zł160.53 Million | zł109.84 Million | zł12.26 Million |
Synektik S.A. - Advanced Valuation Insights
This section examines the relationship between Synektik S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.38 |
| Latest Market Cap to Assets Ratio | 1.34 |
| Asset Growth Rate (YoY) | 30.3% |
| Total Assets | zł489.11 Million |
| Market Capitalization | $654.44 Million USD |
Valuation Analysis
Above Book Valuation: The market values Synektik S.A.'s assets above their book value (1.34x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Synektik S.A.'s assets grew by 30.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Synektik S.A. (2010–2025)
The table below shows the annual total assets of Synektik S.A. from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | zł489.11 Million ≈ $134.61 Million |
+30.34% |
| 2024-12-31 | zł375.26 Million ≈ $103.28 Million |
+25.12% |
| 2023-12-31 | zł299.92 Million ≈ $82.54 Million |
+26.82% |
| 2022-12-31 | zł236.48 Million ≈ $65.08 Million |
+48.09% |
| 2021-12-31 | zł159.69 Million ≈ $43.95 Million |
+12.76% |
| 2020-12-31 | zł141.61 Million ≈ $38.97 Million |
+13.20% |
| 2019-12-31 | zł125.10 Million ≈ $34.43 Million |
+15.20% |
| 2018-12-31 | zł108.59 Million ≈ $29.88 Million |
-5.77% |
| 2017-12-31 | zł115.23 Million ≈ $31.71 Million |
+26.97% |
| 2016-12-31 | zł90.75 Million ≈ $24.98 Million |
-13.08% |
| 2015-12-31 | zł104.40 Million ≈ $28.73 Million |
-2.24% |
| 2014-12-31 | zł106.79 Million ≈ $29.39 Million |
+1.60% |
| 2013-12-31 | zł105.11 Million ≈ $28.93 Million |
+70.74% |
| 2012-12-31 | zł61.56 Million ≈ $16.94 Million |
+21.99% |
| 2011-12-31 | zł50.47 Million ≈ $13.89 Million |
+304.05% |
| 2010-12-31 | zł12.49 Million ≈ $3.44 Million |
-- |
About Synektik S.A.
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics … Read more